The next frontier: Fostering innovation by improving health data access and utilization
Name
Oye_et_al-2015-Clinical_Pharmacology_&_Therapeutics.pdf
Size
557.35 KB
Format
Adobe PDF
Checksum (MD5)
9628bbf763be50258c10f05ccdf921fe
Author(s) • • • • • • • • •
Oye, Kenneth A.
Jain, Gagan
Amador, M.
Arnaout, R.
Brown, J. S.
Crown, W.
Ferguson, J.
Pezalla, E.
Rassen, J. A.
Selker, H. P.
Date Issued
August 2015
Journal
Clinical Pharmacology & Therapeutics
Publisher
Wiley Blackwell
Citation
Oye, KA, G Jain, M Amador, R Arnaout, JS Brown, W Crown, J Ferguson, et al. “The Next Frontier: Fostering Innovation by Improving Health Data Access and Utilization.” Clin. Pharmacol. Ther. 98, no. 5 (September 10, 2015): 514–521.
Version
Final published version
Abstract
Beneath most lively policy debates sit dry-as-dust theoretical and methodological discussions. Current disputes over the EU Adaptive Pathways initiative and the proposed US 21st Century Cures Act may ultimately rest on addressing arcane issues of data curation, standardization, and utilization. Improved extraction of inform ation on the safety and effectiveness of drugs-in-use must parallel adjustments in evidence requirements at the time of licensing. To do otherwise may compromise safety and efficacy in the name of fostering innovation.
MIT Department
Massachusetts Institute of Technology. Center for Biomedical Innovation
Massachusetts Institute of Technology. Department of Political Science
Terms of Use
Creative Commons Attribution-Noncommercial
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1002/cpt.191